Navigation Links
Cephalon Announces Strong Third Quarter Financial Results
Date:11/8/2007

- 12,417 (9)

Write-off of deferred debt issuance

costs - 13,105 (10)

Gain on extinguishment of debt (5,319)(4) -

Gain on sale of investment (5,791)(5) -

Income taxes (40,459)(6) (44,060)(6) (11)

479,167 92,551

ADJUSTED NET INCOME $243,281 $242,276

BASIC ADJUSTED INCOME PER COMMON

SHARE $3.66 $4.01

DILUTED ADJUSTED INCOME PER COMMON

SHARE $3.09 $3.52

WEIGHTED AVERAGE NUMBER OF COMMON

SHARES OUTSTANDING 66,398 60,415

WEIGHTED AVERAGE NUMBER OF COMMON

SHARES OUTSTANDING-ASSUMING DILUTION 78,814 68,921 Notes to Reconciliation of GAAP Net Income (Loss) to Adjusted Net Income

(1) In 2007, to exclude the on-going amortization of acquired intangible

assets. In 2006, to exclude the reserve for SPARLON capitalized

inventory costs ($8.6 million) and the on-going amortization of

acquired intangible assets ($60.8 million).

(2) In 2007, to exclude charges related to payments for several research

and development collaborations ($26.5 million) and the recognition of

a milestone related to the FDA's acceptance of our NDA filing for

TREANDA ($15.0 million). In 2006, to exclude charges related to

payments for several research and development collaborations.

(3) To exclude the reserve established for the agreement in principle

reached with the U.S. Attorney's Office in Philadelphia.

(4) To exclude the forgiveness of a mortgage loan by the PIDA.

(5) To exclude the pre-tax gain related to the sale of ce
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... CA (PRWEB) January 15, 2014 ... research solutions, today announced that Lupin Limited, one of ... Freeslate’s CM Protégé PharmD System for high ... Mumbai, India, is focused on a wide range of ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
(Date:1/14/2014)... and BETHESDA, Md. , Jan. ... together with two institutes from the National Institutes of ... for bringing safer, more effective treatments to patients on ... Center for Advancing Translational Sciences (NCATS) and the National ...
(Date:1/14/2014)... ®, provider of RapidResponse ®, a cloud-based supply chain ... S&OP ) service, is proud to be a gold sponsor ... at the Hilton San Diego Bayfront, January 30 – 31, ... , Director of Supply Chain at Amgen, as she presents ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... FREMONT, Calif., Dec. 14 Vermillion, Inc. (Pink Sheets: ... Wallen, Ph.D. Chief Scientific Officer, Senior Vice President, Research ... board of directors upon confirmation of Vermillion,s bankruptcy plan. ... and development experience in diagnostics and biotechnology," said Gail ...
... , , , NATICK, Mass., Dec. ... announced the completion of a public offering of $2 billion aggregate ... statement. The public offering consists of $850 million of 4.50 ... due January 2020 and $300 million of 7.375 percent notes due ...
... ... the delivery of Brookfield Engineering’s Powder Flow Tester – helping Brookfield move from sheet ... , ... December 14, 2009 -- ThermoFab, a US-based thermoforming company, has completed the delivery of ...
Cached Biology Technology:Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2
(Date:4/17/2014)... One day about eight years ago, Katia Silvera ... and her father were on a field trip in a ... orchid they had never seen before. , Unable to identify ... The orchid turned out to be an unnamed species. ... silverarum . , "Lophiaris" is the genus name, comprising about ...
(Date:4/17/2014)... of forests in the Amazon help create tinderbox ... rapid and widespread forest loss during drought years, ... show that forests in the Amazon could reach ... forest fires lead to large-scale loss of trees, ... professor of geography, Penn State. , "We documented ...
(Date:4/17/2014)... reporting in the Cell Press journal Current Biology ... with rather novel sex lives. The Brazilian insects, which ... Neotrogla , are the first example of an ... has been identified in several different animals, Neotrogla ... organ is also reversed," says Kazunori Yoshizawa from Hokkaido ...
Breaking Biology News(10 mins):Orchid named after UC Riverside researcher 2Orchid named after UC Riverside researcher 3Drought and fire in the Amazon lead to sharp increases in forest tree mortality 2Drought and fire in the Amazon lead to sharp increases in forest tree mortality 3In sex-reversed cave insects, females have the penises 2
... Solution Enables Schools to Help Meet Federal Meal Reimbursement ... ... Pa., Oct. 20 ,BIO-key International, Inc. (OTC Bulletin Board: BKYI), a ... leader in providing biometric finger scanning ID,for schools, announced today a ...
... form of mercury found in the blood of marine ... seals than has previously been thought. Research published in ... shows that MeHg harms T-lymphocytes, key cells in a ... human lymphocytes. Mercury exposure is known to occur ...
... The Earth is in the midst of the sixth ... percent of all species disappearing, scientists say. Because of ... day and night to determine which species must be saved. ... published this week in the Proceedings of the National ...
Cached Biology News:identiMetrics & BIO-key(R) Provide Biometric Finger Scanning for School Food Service Nationwide 2identiMetrics & BIO-key(R) Provide Biometric Finger Scanning for School Food Service Nationwide 3identiMetrics & BIO-key(R) Provide Biometric Finger Scanning for School Food Service Nationwide 4Current mass extinction spurs major study of which plants to save 2Current mass extinction spurs major study of which plants to save 3
Black 96 Well Plate EB, RE Bottom...
96 Well Plate EB, RE bottom; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes. Guaranteed coefficient of variation (CVs)....
...
Immulon 1 B 1x12 Strip, flat bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
Biology Products: